Triveni Bio

BiotechnologySeries CWatertown, UStriveni.bio

Latest round

Series C

Last raised

Jun 2026

Total raised

$272M

Investors

18

About Triveni Bio

a. Amagma Therapeutics. Triveni Bio, Inc. formed by merger of Amagma Therapeutics & Modify Therapeutics, operates as a biotechnology company that focuses on a genetics-informed precision medicine approach to develop functional antibodies for the treatment of I&I disorders. In June 2026, Triveni Bio, Inc. Evan Rachlin MD and Co-Founder and Managing Partner of Ascenta Capital joins the Board of Directors. The company's flagship antibody program, TRIV-509, offers patients with atopic dermatitis and other barrier diseases a significant and much-needed potential therapy option. will be used to advance the clinical development of its pipeline, including initiating a Phase II clinical proof-of-concept study for TRIV-573 in atopic dermatitis later this year, while also progressing its bispecific antibody program and primary atopic dermatitis asset.

Who invested in Triveni Bio

18 investors across 3 rounds

See all investors in Triveni Bio

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series C

    Jun 17, 2026

    Amount

    $65M

    Investors

    Locked

  2. Series B

    Oct 2, 2024

    Amount

    $115M

    Investors

    Locked

  3. Series A

    Oct 26, 2023

    Amount

    $92M

    Investors

    Locked

Questions about Triveni Bio

Who invested in Triveni Bio?

Triveni Bio has 18 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Triveni Bio raised?

Triveni Bio has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did Triveni Bio last raise money?

Triveni Bio's most recent round on record is a Series C, in Jun 2026.

What does Triveni Bio do?

Triveni Bio is a biotechnology company.

Where is Triveni Bio headquartered?

Triveni Bio is headquartered in Watertown, US.

Which VCs invest in companies like Triveni Bio?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Triveni Bio's stage. Their profiles are linked below.

Raising like Triveni Bio? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.